BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36707770)

  • 1. MR imaging phenotypes and features associated with pathogenic mutation to predict recurrence or metastasis in breast cancer.
    Shao Z; Yu J; Cheng Y; Ma W; Liu P; Lu H
    BMC Cancer; 2023 Jan; 23(1):97. PubMed ID: 36707770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
    Ashraf AB; Daye D; Gavenonis S; Mies C; Feldman M; Rosen M; Kontos D
    Radiology; 2014 Aug; 272(2):374-84. PubMed ID: 24702725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters.
    Lee J; Kim SH; Kang BJ
    Sci Rep; 2020 May; 10(1):7598. PubMed ID: 32371907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation.
    Noh JM; Han BK; Choi DH; Rhee SJ; Cho EY; Huh SJ; Park W; Park H; Nam SJ; Lee JE; Kil WH
    J Breast Cancer; 2013 Sep; 16(3):308-14. PubMed ID: 24155760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores.
    Dialani V; Gaur S; Mehta TS; Venkataraman S; Fein-Zachary V; Phillips J; Brook A; Slanetz PJ
    Radiology; 2016 Aug; 280(2):370-8. PubMed ID: 26937802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
    Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
    Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence.
    Chitalia RD; Rowland J; McDonald ES; Pantalone L; Cohen EA; Gastounioti A; Feldman M; Schnall M; Conant E; Kontos D
    Clin Cancer Res; 2020 Feb; 26(4):862-869. PubMed ID: 31732521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of preoperative breast MRI features with locoregional recurrence after breast conservation therapy.
    Bae MS; Chang JM; Cho N; Han W; Ryu HS; Moon WK
    Acta Radiol; 2018 Apr; 59(4):409-417. PubMed ID: 28747131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distant metastasis prediction via a multi-feature fusion model in breast cancer.
    Ma W; Wang X; Xu G; Liu Z; Yin Z; Xu Y; Wu H; Baklaushev VP; Peltzer K; Sun H; Kharchenko NV; Qi L; Mao M; Li Y; Liu P; Chekhonin VP; Zhang C
    Aging (Albany NY); 2020 Sep; 12(18):18151-18162. PubMed ID: 32989175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic, US, and MR imaging phenotypes of familial breast cancer.
    Schrading S; Kuhl CK
    Radiology; 2008 Jan; 246(1):58-70. PubMed ID: 18096529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
    Song Y; Barry WT; Seah DS; Tung NM; Garber JE; Lin NU
    Cancer; 2020 Jan; 126(2):271-280. PubMed ID: 31581314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
    Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
    AJR Am J Roentgenol; 2017 Oct; 209(4):920-928. PubMed ID: 28796549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review.
    Maimone S; Harper LK; Mantia SK; Advani PP; Hochwald AP; Li Z; Hines SL; Patel B
    Eur J Radiol; 2023 May; 162():110788. PubMed ID: 36948059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.
    Chae EY; Jung MR; Cha JH; Shin HJ; Choi WJ; Kim HH
    Eur Radiol; 2024 May; ():. PubMed ID: 38787429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
    Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
    Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer: A preliminary study.
    Tokuda Y; Yanagawa M; Minamitani K; Naoi Y; Noguchi S; Tomiyama N
    Medicine (Baltimore); 2020 Apr; 99(16):e19664. PubMed ID: 32311939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancer.
    You C; Xiao Q; Zhu X; Sun Y; Di G; Liu G; Hou Y; Chen C; Wu J; Shao Z; Gu Y; Hu Z
    Gland Surg; 2021 Jan; 10(1):262-272. PubMed ID: 33633982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
    Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
    Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Oncotype DX recurrence score and dynamic contrast-enhanced MRI features in patients with estrogen receptor-positive HER2-negative invasive breast cancer.
    Kim HJ; Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
    Clin Imaging; 2021 Jul; 75():131-137. PubMed ID: 33548871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival.
    Kim JY; Kim JJ; Hwangbo L; Suh HB; Kim S; Choo KS; Nam KJ; Kang T
    Radiology; 2020 Jun; 295(3):517-526. PubMed ID: 32228293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.